参考文献/References:
[1] 中华医学会心血管病学分会.中国部分地区1980、1990、2000年慢性心力衰竭住院病例回顾性分析调查[J].中华心血管病杂志,2002,30(8):450-454.
[2] Kannel WB, Castelli WP, McNamara PM, et al.Role of blood pressure in the development of congestive heart failure—the Framingham study[J].N Engl J Med,1972,287:781-787.
[3] Levy D, Larson MG, Vasan RS, et al.The progression from hypertension to congestive heart failure[J].JAMA,1996,275(20):1557-1562.
[4] Hsia J, Margolis KL, Eaton CB, et al.Prehypertension and cardiovascular disease risk in the Women's Health Initiative[J].Circulation,2007,115(7):855-860.
[5] Psaty BM, Lumley T, Furberg CD, et al.Health outcomes associated with various antihypertensive therapies used as first-line agents:a network meta-analysis[J].JAMA,2003,289(19):2534-2544.
[6] Nigel S, Beckett NS, Ruth PR, et al.Treatment of hypertension in patients 80 years age or older[J].N Engl J Med,2008,358:1887-1898.
[7] 中华医学会心血管病学分会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.
[8] McMurray JJ, Adamopoulos S, Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2012,33(14):1787-1847.
[9] Yancy CW, Jessup M, Bozkurt B, et al.2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].Circulation,2013,128(16):E240-E327.
[10] González A, López B, Querejeta R,et al.Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction[J].Hypertension,2010, 55(6):1418-1424.
[11] Dunlay SM, Roger VL,Weston SA, et al.Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction[J].Circ Heart Fail,2012,5(6): 720-726.
[12] Borlaug BA, Olson TP, Lam CS, et al.Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction[J].J Am Coll Cardiol,2010,56(11):845-854.
[13] Borlaug BA,Nishimura RA,Sorajja P,et al.Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction[J].Circ Heart Fail,2010,3(5):588-595.
[14] Kato T,Niizuma S,Inuzuka Y,et al.Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure[J].Circ Heart Fail,2010,3(3):420-430.
[15] Paulus WJ, Tschpe CA.Novel paradigm for heart failure with preserved ejection fraction:comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation[J].J Am Coll Cardiol,2013,62(4):263-271.
[16] Borlaug BA, Redfield MM.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum[J].Circulation,2011,123(18):2006-2013.
[17] Bursi F, Weston SA, Redfield MM, et al.Systolic and diastolic heart failure in the community[J].JAMA,2006,296(18):2209-2216.
[18] Steinberg BA, Zhao X, Heidenreich PA,et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence,therapies,and outcomes[J].Circulation,2012,126(1):65-75.
[19] Lee D,Floras J,Newton G,et al.Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure[J].Circ Heart Fail,2009,2(6):616-623.
[20] Muntwyler J, Abetel G, Gruner C,et al.One-year mortality among unselected outpatients with heart failure[J].Eur Heart J,2002,23(23):1861-1866.
[21] Berry C,Doughty RN,Granger C,et al.The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction:an individual patient data meta-analysis[J].Eur Heart J,2012,33(14):1750-1757.
[22] Joffe SW, Phillips RA.Treating hypertension in patients with left ventricular dysfunction: hitting the fairway and avoiding rough[J].Curr Heart Fail Rep,2013,10:157-164.
[23] Belardinelli R, Georgiou D, Cianci G, et al.10-year exercise training in chronic heart failure: a randomized controlled trial[J].J Am Coll Cardiol,2012,60(16):1521-1528.
[24] O'Connor CM,Whellan DJ,Lee KL, et al.Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial[J].JAMA,2009,301(14):1439-1450.
[25] Hunt SA, Abraham WT, Chin MH, et al.Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation[J].Circulation,2009,119:e391.
相似文献/References:
[1]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(2):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[2]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(2):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[3]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(2):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[4]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(2):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[5]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(2):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[6]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(2):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[7]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[8]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(2):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[9]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(2):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[10]付士辉李玉龙骆雷鸣沈明志田进文邓珏琳.高血压基础研究现状与进展[J].心血管病学进展,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
FU ShihuiLI YulongLUO LeimingSHEN MingzhiTIAN JinwenDENG Juelin.Status and Progress of Basic Researches about Hypertension[J].Advances in Cardiovascular Diseases,2019,(2):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]